✦ LIBER ✦

8514 SPECTRUM, a phase III trial for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) receiving chemotherapy with or without panitumumab: interim pooled safety analysis

✍ Scribed by Stöhlmacher, J.; Davidenko, I.; Winquist, E.; Licitra, L.; Skladowski, K.; Ciuleanu, T.E.; Kumar, R.R.; Foa, P.; Gansert, J.; Vermorken, J.B.

Book ID: 122361843
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 71 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71605-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8519 A phase 2, randomized trial (CONCER

8519 A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis

✍ Fortin, A.; Cmelak, A.; Mesía, R.; Minn, H.; Chan, A.T.C.; Yunes, A.C.; Merlano, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Cisplatin and fluorouracil with or witho

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

✍ Vermorken, Jan B; Stöhlmacher-Williams, Jan; Davidenko, Irina; Licitra, Lisa; Wi 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 615 KB

Impact of tumor HPV status on outcome in

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

✍ Vermorken, J. B.; Psyrri, A.; Mesia, R.; Peyrade, F.; Beier, F.; de Blas, B.; Ce 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 176 KB

8516 A phase 2 randomized trial of radio

8516 A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis

✍ Giralt, J.; Trigo, J.M.; Nuyts, S.; Ozsahin, M.; Markowitz, A.B.; Daisne, J.; Sk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A Phase II Trial of Bryostatin-1 in Pati

A Phase II Trial of Bryostatin-1 in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

✍ David G. Pfister; John McCaffrey; Andrew J. Zahalsky; Gary K. Schwartz; Eric Lis 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 77 KB

A phase II trial of cisplatin and vinore

A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Enrique Espinosa; Pilar Zamora; Alfredo Millá; Serafin Morales; Raquel Molina; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv